Founded in 2011 as a spin-off of the University of Basel, Switzerland, PIQUR Therapeutics AG developed targeted oncology and dermatology medicines for the treatment of cancers and genetic diseases.
View Top Employees from PIQUR Therapeutics AGWebsite | http://www.piqur.com |
Revenue | $5 million |
Funding | $20.2 million |
Employees | 14 (4 on RocketReach) |
Founded | 2011 |
Address | Hochbergerstrasse 60C, Basel, Basel-City 4057, CH |
Phone | +41 61 551 20 50 |
Technologies |
HTML,
Twitter,
Cisco WebEx
+1 more
(view full list)
|
Industry | Pharmaceuticals, Business Services General, Biotechnology, Oncology, Executive Office, Business Services, Science and Engineering, Small Molecules, Health Care, Hematology, Medical, Drug Development, Pharmaceutical |
Web Rank | 12 Million |
Keywords | Piqur Therapeutics |
Competitors | Abivax, Cancer Prevention Pharmaceuticals, Inc, G1 Therapeutics, Inc., Moleculin Biotech, Inc., TYME Technologies Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular PIQUR Therapeutics AG employee's phone or email?
The PIQUR Therapeutics AG annual revenue was $5 million in 2023.
4 people are employed at PIQUR Therapeutics AG.
PIQUR Therapeutics AG is based in Basel, Basel-City.
The NAICS codes for PIQUR Therapeutics AG are [32, 325, 32541, 3254].
The SIC codes for PIQUR Therapeutics AG are [283, 28].